1-20 of 33
Authors: John H. Sampson
Save search
Sort by
Journal Article

TMIC-45. CYTOMEGALOVIRUS PP65 ANTIGEN EXPRESSION FOLLOWING PP65-SPECIFIC DENDRITIC CELL VACCINATION IN MATCHED PRIMARY AND RECURRENT GLIOBLASTOMA SPECIMENS

PDF
Tarek Bou Dargham and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii308, https://doi.org/10.1093/neuonc/noae165.1223
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE

Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial

PDF
John H Sampson and others
Neuro-Oncology, Volume 25, Issue 6, June 2023, Pages 1085–1097, https://doi.org/10.1093/neuonc/noac285
Published: 14 January 2023
Journal Article

HGG-22. PHASE 1b STUDY POLIO VACCINE SABIN-RHINOVIRUS POLIOVIRUS (PVSRIPO) FOR RECURRENT MALIGNANT GLIOMA IN CHILDREN

PDF
David M Ashley and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i93, https://doi.org/10.1093/neuonc/noy059.294
Published: 22 June 2018
Journal Article
EDITOR'S CHOICE

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143

PDF
Antonio Omuro and others
Neuro-Oncology, Volume 20, Issue 5, May 2018, Pages 674–686, https://doi.org/10.1093/neuonc/nox208
Published: 28 October 2017
Journal Article

Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis

PDF
Jessica L Narloch and others
Neuro-Oncology, Volume 19, Issue 10, October 2017, Pages 1391–1397, https://doi.org/10.1093/neuonc/nox090
Published: 03 May 2017
Journal Article

IMST-38. CAR T CELLS INDUCE COMPLETE REGRESSION OF MURINE GLIOBLASTOMA AFTER PRECONDITIONING HOSTS WITH TEMOZOLOMIDE

PDF
Carter M. Suryadevara and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Pages vi94–vi95, https://doi.org/10.1093/neuonc/now212.394
Published: 07 November 2016
Journal Article

IMST-51. DEVELOPMENT OF A PEPTIDE VACCINE PLATFORM FOR BRAIN TUMOR IMMUNOTHERAPY THAT INCORPORATES ADJUVANT CD27 STIMULATION FOR ENHANCED T CELL IMMUNITY

PDF
Katherine Riccione and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi98, https://doi.org/10.1093/neuonc/now212.407
Published: 07 November 2016
Journal Article

IMST-44. LYMPHOPENIA ENHANCES THE EFFICACY OF CAR T CELLS DELIVERED LOCO-REGIONALLY IN THE BRAIN FOR THE TREATMENT OF GLIOBLASTOMA

PDF
Carter M. Suryadevara and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi96, https://doi.org/10.1093/neuonc/now212.400
Published: 07 November 2016
Journal Article

IMST-45. A FULLY-HUMAN EGFRvIII-TARGETED BISPECIFIC ANTIBODY REDIRECTS HUMAN T CELLS TO SPECIFICALLY LYSE MALIGNANT GLIOMA

PDF
Patrick C. Gedeon and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi96, https://doi.org/10.1093/neuonc/now212.401
Published: 07 November 2016
Journal Article

IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA

PDF
David A. Reardon and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v109, https://doi.org/10.1093/neuonc/nov218.08
Published: 09 November 2015
Journal Article

Vaccination strategies for neuro-oncology

PDF
John H. Sampson and Duane A. Mitchell
Neuro-Oncology, Volume 17, Issue suppl_7, November 2015, Pages vii15–vii25, https://doi.org/10.1093/neuonc/nov159
Published: 29 October 2015
Journal Article

Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma

PDF
Gordana Vlahovic and others
Neuro-Oncology, Volume 17, Issue 8, August 2015, Pages 1043–1045, https://doi.org/10.1093/neuonc/nov071
Published: 10 May 2015
Journal Article
EDITOR'S CHOICE

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study Get access

PDF
James Schuster and others
Neuro-Oncology, Volume 17, Issue 6, June 2015, Pages 854–861, https://doi.org/10.1093/neuonc/nou348
Published: 13 January 2015
Journal Article
EDITOR'S CHOICE

Immunotherapy advances for glioblastoma Get access

PDF
David A. Reardon and others
Neuro-Oncology, Volume 16, Issue 11, November 2014, Pages 1441–1458, https://doi.org/10.1093/neuonc/nou212
Published: 04 September 2014
Journal Article

PATIENT-DERIVED XENOGRAFTS MIRROR THE PROTEOMIC PROFILE OF HUMAN GLIOBLASTOMA: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT Get access

PDF
Madan M. Kwatra and others
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii38, https://doi.org/10.1093/neuonc/nou208.57
Published: 01 July 2014
Journal Article

IDH1 MUTATIONS AS A IMMUNOTHERAPEUTIC TARGET FOR BRAIN TUMORS Get access

PDF
Gary E. Archer and others
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii40, https://doi.org/10.1093/neuonc/nou208.65
Published: 01 July 2014
Journal Article

ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN RECURRENT GLIOBLASTOMA (GBM): FIRST PHASE I CLINICAL TRIAL EVALUATING THE INTRATUMORAL ADMINISTRATION Get access

PDF
Annick Desjardins and others
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii43, https://doi.org/10.1093/neuonc/nou209.5
Published: 01 July 2014
Journal Article

Editorial on “Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial” Get access

PDF
John H. Sampson and Gordana Vlahovic
Neuro-Oncology, Volume 16, Issue 2, February 2014, Pages 169–170, https://doi.org/10.1093/neuonc/not311
Published: 01 February 2014
Journal Article

Epidermal growth factor receptor and variant III targeted immunotherapy Get access

PDF
Kendra L. Congdon and others
Neuro-Oncology, Volume 16, Issue suppl_8, October 2014, Pages viii20–viii25, https://doi.org/10.1093/neuonc/nou236
Published: 01 January 2014
Journal Article

Clinical trial end points for high-grade glioma: the evolving landscape Get access

PDF
David A. Reardon and others
Neuro-Oncology, Volume 13, Issue 3, March 2011, Pages 353–361, https://doi.org/10.1093/neuonc/noq203
Published: 01 March 2011